Investors Overview

Corporate Profile
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit
ExchangeTSX (Canadian Dollar)
Change (%) Stock is Down 0.02 (1.63%)
Data as of 07/11/19 1:37 p.m. ET
Refresh quote
Recent NewsMore >>
06/12/19Cipher Pharmaceuticals Reports Voting Results for the Election of DirectorsPrinter Friendly Version
02/28/18Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to FDA-Approved TRULANCE® from Synergy PharmaceuticalsPrinter Friendly Version
06/02/17Cipher Pharmaceuticals Adds New Vice President of Corporate DevelopmentPrinter Friendly Version
Featured Documents
Download Documentation Q1 Report
Download Documentation 2016 AGM Presentation
Download Documentation 2016 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Cipher Pharmaceuticals Inc posts new information to the site. Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources